Literature DB >> 11278829

A quantitative molecular model for modulation of mammalian translation by the eIF4E-binding protein 1.

M M Karim1, J M Hughes, J Warwicker, G C Scheper, C G Proud, J E McCarthy.   

Abstract

Translation initiation is a key point of regulation in eukaryotic gene expression. 4E-binding proteins (4E-BPs) inhibit initiation by blocking the association of eIF4E with eIF4G, two integral components of the mRNA cap-binding complex. Phosphorylation of 4E-BP1 reduces its ability to bind to eIF4E and thereby to compete with eIF4G. A novel combination of biophysical and biochemical tools was used to measure the impact of phosphorylation and acidic side chain substitution at each potentially modulatory site in 4E-BP1. For each individual site, we have analyzed the effects of modification on eIF4E binding using affinity chromatography and surface plasmon resonance analysis, and on the regulatory function of the 4E-BP1 protein using a yeast in vivo model system and a mammalian in vitro translation assay. We find that modifications at the two sites immediately flanking the eIF4E-binding domain, Thr(46) and Ser(65), consistently have the most significant effects, and that phosphorylation of Ser(65) causes the greatest reduction in binding affinity. These results establish a quantitative framework that should contribute to understanding of the molecular interactions underlying 4E-BP1-mediated translational regulation.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11278829     DOI: 10.1074/jbc.M011068200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  23 in total

1.  Hierarchical phosphorylation of the translation inhibitor 4E-BP1.

Authors:  A C Gingras; B Raught; S P Gygi; A Niedzwiecka; M Miron; S K Burley; R D Polakiewicz; A Wyslouch-Cieszynska; R Aebersold; N Sonenberg
Journal:  Genes Dev       Date:  2001-11-01       Impact factor: 11.361

2.  Local control of a disorder-order transition in 4E-BP1 underpins regulation of translation via eIF4E.

Authors:  Shirley Tait; Kaushik Dutta; David Cowburn; Jim Warwicker; Andrew J Doig; John E G McCarthy
Journal:  Proc Natl Acad Sci U S A       Date:  2010-09-28       Impact factor: 11.205

3.  Differential effects of insulin and dietary amino acids on muscle protein synthesis in adult and old rats.

Authors:  Magali Prod'homme; Michèle Balage; Elisabeth Debras; Marie-Chantal Farges; Scott Kimball; Leonard Jefferson; Jean Grizard
Journal:  J Physiol       Date:  2004-10-28       Impact factor: 5.182

4.  Parkin modulates gene expression in control and ceramide-treated PC12 cells.

Authors:  P G Unschuld; J Dächsel; F Darios; A Kohlmann; E Casademunt; K Lehmann-Horn; M Dichgans; M Ruberg; A Brice; T Gasser; C B Lücking
Journal:  Mol Biol Rep       Date:  2006-03       Impact factor: 2.316

5.  Regulation of protein synthesis by ionizing radiation.

Authors:  Steve Braunstein; Michelle L Badura; Qiaoran Xi; Silvia C Formenti; Robert J Schneider
Journal:  Mol Cell Biol       Date:  2009-08-24       Impact factor: 4.272

6.  Molecular mechanism of the dual activity of 4EGI-1: Dissociating eIF4G from eIF4E but stabilizing the binding of unphosphorylated 4E-BP1.

Authors:  Naotaka Sekiyama; Haribabu Arthanari; Evangelos Papadopoulos; Ricard A Rodriguez-Mias; Gerhard Wagner; Mélissa Léger-Abraham
Journal:  Proc Natl Acad Sci U S A       Date:  2015-07-13       Impact factor: 11.205

7.  Translational control of cell fate: availability of phosphorylation sites on translational repressor 4E-BP1 governs its proapoptotic potency.

Authors:  Shunan Li; Nahum Sonenberg; Anne-Claude Gingras; Mark Peterson; Svetlana Avdulov; Vitaly A Polunovsky; Peter B Bitterman
Journal:  Mol Cell Biol       Date:  2002-04       Impact factor: 4.272

8.  Differential phosphorylation controls Maskin association with eukaryotic translation initiation factor 4E and localization on the mitotic apparatus.

Authors:  Daron C Barnard; Quiping Cao; Joel D Richter
Journal:  Mol Cell Biol       Date:  2005-09       Impact factor: 4.272

9.  Active-site inhibitors of mTOR target rapamycin-resistant outputs of mTORC1 and mTORC2.

Authors:  Morris E Feldman; Beth Apsel; Aino Uotila; Robbie Loewith; Zachary A Knight; Davide Ruggero; Kevan M Shokat
Journal:  PLoS Biol       Date:  2009-02-10       Impact factor: 8.029

10.  Screen for chemical modulators of autophagy reveals novel therapeutic inhibitors of mTORC1 signaling.

Authors:  Aruna D Balgi; Bruno D Fonseca; Elizabeth Donohue; Trevor C F Tsang; Patrick Lajoie; Christopher G Proud; Ivan R Nabi; Michel Roberge
Journal:  PLoS One       Date:  2009-09-22       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.